Wild-type (WT) Salmonella typhimurium causes acute intestinal inflammation by activating the nuclear factor kappa B (NF-kB) pathway. Interestingly, WT Salmonella infection also causes degradation of b-catenin, a regulator of cellular proliferation. Regulation of b-catenin and the inhibitor of NF-kB, IkBa, is strikingly similar, involving phosphorylation at identical sites, ubiquitination by the same E3 ligase, and subsequent proteasomal degradation. However, how b-catenin directly regulates the NF-kB pathway during bacteria-induced inflammation in vivo is unknown. Using streptomycinpretreated mice challenged with Salmonella, we demonstrated that WT Salmonella stimulated b-catenin degradation and decreased the physical association between NF-kB and b-catenin. Accordingly, WT Salmonella infection decreased the expression of c-myc, a b-catenin-regulated target gene, and increased the levels of IL-6 and TNF-a, the NF-kB-regulated target genes. Bacterial infection directly stimulated phosphorylation of b-catenin, both in vivo and in vitro. Closer examination revealed that glycogen synthase kinase 3b (GSK-3b) kinase activity was increased in response to WT Salmonella, whereas non-virulent Salmonella had no effect. siRNA of GSK-3b was able to stabilize IkBa in response to WT Salmonella. Pretreatment for 24 h with LiCl, an inhibitor of GSK-3b, reduced WT Salmonella induced IL-8 secretion. Additionally, cells expressing constitutively active b-catenin showed IkBa stabilization and inhibition of NF-kB activity not only after WT Salmonella infection but also after commensal bacteria (Escherichia coli F18) and TNF-a treatment. This study suggests a new role for b-catenin as a negative regulator of inflammation. Bacteria pathogenicity requires overcoming or altering many very effective host defense mechanisms, 1 including the activation of nuclear factor kappa B (NF-kB).
Bacteria pathogenicity requires overcoming or altering many very effective host defense mechanisms, 1 including the activation of nuclear factor kappa B (NF-kB). [2] [3] [4] Bacterial invasion of intestinal epithelial cells (IECs) stimulates NF-kB and, interestingly, degradation of b-catenin, 5 a potent transcriptional factor responsible for cellular proliferation and differentiation. It is notable that regulation of b-catenin and the inhibitor of NF-kB, IkBa, are strikingly similar, involving phosphorylation of the same N-terminal serine sequence sites, ubiquitination by the same E3 ligase complex, and subsequent proteasomal degradation. 6, 7 To date, no publications have reported on the physiological significance of b-catenin's potential inter-relationship with the NF-kB inflammatory pathway after bacterial infection in vivo.
In this study, therefore, we investigated the role of b-catenin in modulating the proinflammatory response mediated by NF-kB subsequent to Salmonella infection in vivo. We examined the possibility that b-catenin functions as a negative regulator of NF-kB, much in the same way as IkBa, through physical interaction with NF-kB. Additionally, we established the role of glycogen synthase kinase 3b (GSK-3b), as the negative regulator of b-catenin's stability and subsequent reactivity with NF-kB in both in vitro and in vivo Salmonella-induced gastroenteritis models. The results of this study suggest a novel role for b-catenin as a negative regulator of NF-kB activity in vivo. Stabilizing of b-catenin has a significant anti-inflammatory effect by reducing NF-kBmediated proinflammatory activity, thus controlling intestinal inflammation.
MATERIALS AND METHODS Bacterial Strains and Growth Conditions
Bacterial strains included wild-type (WT) Salmonella typhimurium ATCC 14028s, S. typhimurium mutant PhoP c and Escherichia coli F18. Bacterial growth conditions were as follows: non-agitated microaerophilic bacterial cultures were prepared by inoculation of 10 ml of Luria-Bertani broth with 0.01 ml of a stationary phase culture, followed by overnight incubation (B18 h) at 371C, as described previously. 5 Cell Culture HCT116 CTNNB1
WT/D45 and its b-catenin knockout derivative lines, HCT116 CTNNB1 À/D45 and CTNNB1 WT/À , were cultured in McCoy's 5A medium supplemented with 10% (vol/vol) fetal bovine serum (FBS). MDCK II cells were grown on permeable supports (0.4 mm pore size) in DMEM supplemented with 10% FBS. The rat small intestinal IEC-18 cell line was grown in DMEM (high glucose, 4.5 g/l) containing 5% (vol/vol) FBS, 0.1 U/ml insulin, 50 mg/ml streptomycin, and 50 U/ml penicillin. The NF-kBp65 knockout mouse embryonic fibroblast (MEF p65À/À) and WT MEF p65 þ / þ were cultured in DMEM supplemented with 10% FBS.
Streptomycin Pre-Treated Mouse Model
Animal experiments were performed at the University of Chicago by using specific pathogen-free female C57BL/6 mice (Taconic) that were 6-7 weeks old. Water and food were withdrawn 4 h before oral gavage with 7.5 mg/mouse of streptomycin (75 ml of sterile solution or 75 ml of sterile water (control)). Afterwards, animals were supplied with water and food ad libitum. Twenty hours after streptomycin treatment, water and food were withdrawn again for 4 h before the mice were infected with 1 Â 10 7 CFU of S. typhimurium (50-ml suspension in HBSS) or treated with sterile HBSS (control) by oral gavage as described previously. 8 At 6 and 18 h after infection, mice were killed, and tissue samples from the intestinal tracts were removed for analysis.
Mouse Colonic Epithelial Cells
Mouse colonic epithelial cells were collected by scraping from mouse colon including proximal and distal regions. Cells were sonicated in lysis buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris pH 7.4, 1 mM EDTA, 1 mM EGTA, pH 8.0, 0.2 mM sodium ortho-vanadate, protease inhibitor cocktail) and the protein concentration was determined (BioRad). bActin was used as the loading control for all Western blots. Villin, an accepted marker of epithelial cells, 9 was used as the control for epithelial cell protein content in all Western blots.
Immunoprecipitation
Immunoprecipitation samples were prepared as described previously. 10 Blots were probed with anti-b-catenin antibody (Transduction Laboratories, USA), stripped and reprobed with anti-p50, anti-p65, anti-IkBa (Santa Cruz Biotechnology, CA, USA) and anti-a-catenin (Zymed, San Diego, CA, USA) antibodies and visualized by enhanced chemiluminescence (ECL). Chemiluminescent signals were collected and scanned from ECL Hyperfilm (Amersham Pharmacia Biotech) with a Scanjet 7400c backlit flatbed scanner (HewlettPackard Co., Palo Alto, CA, USA). For figures, the contrast of images was adjusted, arranged, and labeled in Adobe Photoshop and Adobe Illustrator (Adobe Systems Incorporated, San Jose, CA, USA). Bands were quantified using NIH Image software. The digital images are representative of the original data.
Immunoblotting
Mouse epithelial cells were lysed in lysis buffer (1% Triton X-100, 150 mM NaCl, 10 mM Tris pH 7.4, 1 mM EDTA, 1 mM EGTA pH 8.0, 0.2 mM sodium ortho-vanadate, protease inhibitor cocktail) and the protein concentration was measured. Cultured cells were rinsed twice in ice-cold HBSS, lysed in protein loading buffer (50 mM Tris, pH 6.8, 100 mM dithiothreitol, 2% SDS, 0.1% bromophenol blue, 10% glycerol), and sonicated. Equal amounts of proteins or equal volumes of total cultured cell lysates were separated by SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and immunoblotted with primary antibodies: anti-b-catenin, anti-p50, anti-p65, anti-IkBa, anti-c-myc (Santa Cruz Biotechnology, CA, USA), anti-a-catenin (Zymed, Carlsbad, CA, USA), p-GSK3b (Y216, BD), pGSK3b (Ser9), p-b-catenin (ser33/37/Thr41 and Thr41/ Ser45, Cell Signal, MA, USA) or b-actin (Sigma) antibodies and visualized by ECL.
Immunohistochemistry
Tissues were fixed in 10% neutral buffered formaldehyde for 2 h, transferred into 70% ethanol, and processed the next day. Immunohistochemistry for b-catenin was performed on paraffin-embedded sections (1 mm) of mouse colons. Paraffin sections were baked in an oven at 561C for 20 min. The slides were deparaffinized and rehydrated in xylene, followed by graded ethanol washes at room temperature. Antigen retrieval was achieved by boiling of the slides in a microwave oven in 0.01 M sodium citrate buffer (pH 6.0). Slides were then incubated in hydrogen peroxide (3% H 2 O 2 and 1% FBS in PBS) for 20 min at room temperature to block endogenous peroxidase activity, followed by incubation for 20 min in 5% FBS/PBS to reduce nonspecific background. The samples were incubated with purified mouse anti-b-catenin antibody (BD Transduction Laboratories, BD Biosciences, San Diego, CA, USA; 1:50) in 1% FBS/PBS overnight at 41C. Samples were then incubated with HRP-conjugated second antibody (Envision þ t System/HRP Kit, Dako Cytomation, Glostrup, Denmark) for 1 h at room temperature. Antibody staining was visualized with DAB (Envision þ t System/HRP Kit, Dako Cytomation), counterstained with hematoxylin, and coverslipped.
Immunofluorescence Colonic tissues from the proximal and distal portion of the colon were freshly isolated and embedded in paraffin wax after fixation with 10% neutral buffered formalin. After preparation of the slides as described above, slides were incubated in 3% H 2 O 2 for 20 min at room temperature to Quantitative Real-Time PCR Analysis Total RNA was extracted from epithelial cells using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and reverse transcribed using the iScript cDNA synthesis kit (BioRad, Hercules, CA, USA) according to the manufacturer's directions. The RT cDNA reaction products were subjected to quantitative real-time PCR using the MyiQ single-color real-time PCR detection system (BioRad) and iQ SYBR green supermix (BioRad) according to the manufacturer's directions. IL-8 cDNA was amplified using primers to the human IL-8 gene that are complementary to regions in exon 1 (5 0 -TGCATAA AGACATACTCCAAACCT) and overlapping the splice site between exons 3 and 4 (5 0 -AATTCTCAGCCCTCTTCAAA AA). All expression levels were normalized to the GAPDH levels of the same sample, using forward (5 0 -CTTCACCACC ATGGAGAAGGC) and reverse (5 0 -GGCATGGACTGTGGTC ATGAG) primers for GAPDH. Percent expression was calculated as the ratio of the normalized value of each sample to that of the corresponding untreated control cells. All realtime PCR reactions were performed in triplicate. All PCR primers were designed using Lasergene software (DNAStar Inc., Madison, WI, USA).
Salmonella-Induced Mouse IL-6 and TNF-a Secretion Mouse blood samples were collected by cardiac puncture and placed in tubes containing EDTA (10 mg/ml). Mouse IL-6 and TNF-a were measured using the TiterZyme Enzyme Immunometric Assay kits (Assay Designs Inc., Ann Arbor, MI, USA) according to the manufacturer's instructions.
Salmonella-Induced Human IL-8 Secretion HT29-C19A or T84 cells plated on inserts were incubated with LiCl (30 nM) in DMEM for 24 h, followed by Salmonella-containing HBSS (1.6 Â 10 10 bacteria/ml) apically for 30 min, washing 3 Â in HBSS, and incubation at 371C for 4 h. Cell supernatants from the basolateral side were removed and assayed for IL-8 by ELISA in 96-well plates (Linbro/ Titertek; ICN Biochemicals, Costa Mesa, CA, USA) as described previously. 10 
Statistical Analysis
Data are expressed as mean7s.d. Differences were analyzed by Student's t-test. P-values r0.05 were considered significance.
RESULTS

Direct Physical Interaction between NF-jB/b-Catenin in the Mouse Colon
To investigate physical interaction between NF-kB and b-catenin (NF-kB/b-catenin) in mucosal inflammation in vivo, we utilized an animal model of bacterial infection after pretreatment with streptomycin. Streptomycin pretreatment reduces the commensal bacteria in the mouse gut and renders the mouse susceptible to Salmonella-induced gastroenteritis. 8 PhoP c is a PhoP-PhoQ constitutive mutation of the WT Salmonella strain 14028s 11 In cells not exposed to the stimulation, b-catenin levels are kept low through interactions with GSK-3b, adenomatous polyposis coli (APC), and Axin in the cytoplasm. [12] [13] [14] As positive control, immunoprecipitation with APC was able to pull down b-catenin (Figure 1d ). Immunoprecipitation with IgG was used as a negative control and failed to pull down p65, as shown in Figure 1c and d.
We further assessed whether the b-catenin/NF-kB complex was independent of the APC/GSK3b/b-catenin complex. Immunoprecipitation with APC and GSK-3b was able to pull down b-catenin and p65 in mouse epithelial cells (Figure 1d and e). Bacterial infection decreased the p65 pulled down by GSK-3b, but did not change the amount of GSK-3b/b-catenin complex (Figure 1e ).
Additionally, we tested the b-catenin/NF-kB complex in NF-kBp65 MEF p65À/À. As shown in Figure 1e , p65 was absent in the p65À/À MEF. The level of b-catenin protein was slightly reduced in p65À/À cells (Figure 1f ). Co-immunoprecipitation assays showed that anti-b-catenin antibody was able to pull down p65 protein in p65 þ / þ MEFs, but not in p65À/À cells ( Figure 1g , b-catenin). Immunoprecipitation of APC or GSK-3b pulled down p65 in WT MEF p65 þ / þ , but not in the p65À/À MEF ( Figure 1g , APC and GSK-3b). NF-kBp50 and p65 are two subunits of NF-kB. As positive control, the NF-kBp50 subunit was associated with p65 in p65 þ / þ . The p65/p50 association was abolished in p65À/À (Figure 1g ). These data confirm the existence of b-catenin-p65 interaction in mouse fibroblasts. They also suggest that there was binding between NF-kB, GSK-3b, and APC.
Taken together, the findings illustrated in Figure 1 were immunoprecipitated with antibodies against b-catenin, APC, GSK-3b, or p50, and sequentially Western blotted with antibodies against NF-kBp65. In all instances, the numbers shown represent the relative band intensity compared to control with no treatment (À). Relative band intensities were determined using NIH Image software, and were normalized to control (À) for each sample, which was arbitrarily set to 100. Images shown are representative of 2-3 trials.
b-Catenin activity and inflammation Y Duan et al action of NF-kBp50 with a-catenin, a family member of b-catenin (unpublished data), or with a nonspecific IgG, indicating that the physical interaction between b-catenin and NF-kB determined in vivo is specific.
Localization of b-Catenin and NF-jB during Inflammation
The intestinal epithelium lining the gastrointestinal tract has a well-defined architecture. In the normal intestine, there are b-catenin repression, cell-cycle arrest, and terminal differentiation along the crypt to the villus axis. The crypt-villus junction is also under the control of b-catenin signaling. In order to investigate the subcellular distribution of b-catenin and NF-kBp65 in the intact colon, tissue sections from mice with or without bacterial colonization were generated and stained with anti-b-catenin and anti-NF-kBp65 antibodies.
In the normal colon, without any treatment, NF-kB was localized in the cytoplasm, and most of the b-catenin pro- The immunohistochemistry results shown in Figure 2d support the fluorescence staining in Figure 2a , b, and c. In the normal colon, most of the b-catenin proteins were located around the cell membrane and in the cytoplasm (Figure 2d, control) . The b-catenin staining in WT Salmonella-treated colons was very light compared to that of the controls and PhoP c -treated mice in the lower crypts and cell membrane. In PhoP c -treated mice, the nuclear staining of b-catenin was visible in the lower part of the crypts (Figure 2d , PhoP c ), as indicated by black arrowheads.
Bacterial Infection Changes the Expression of Target Genes in b-Catenin Pathways
The effect of bacterial colonization on the expression of the b-catenin transcriptionally regulated target gene, c-myc, 11 was investigated in a streptomycin-pretreated mouse model. After infection with either the WT or the avirulent PhoP c , colonic c-myc levels were determined from IEC lysates. As shown in Figure 3a , c-myc expression decreased to about 40% of the normal control after infection with WT Salmonella for 18 h, but did not decrease when infected with PhoP c . C-myc has an essential function in cellular growth and proliferation. 15 In addition, cyclin D1, a target gene of the bcatenin pathway, and PCNA, a marker of proliferation, were also decreased by WT Salmonella infection (data not shown).
Bacterial Infection Changes the Secretion of IL-6 and TNF-a, the NF-jB Target Genes Colonization of cells with WT Salmonella resulted in the dissociation of NF-kB from IkBa allowing NF-kB to translocate to the nucleus, where it binds to its recognition sites in the promoter region of a wide variety of genes, including IL-8 (humans) or IL-6 (mouse). IL-6 secretion in mouse plasma (Figure 3b ) was observed after WT Salmonella colonization. In vivo colonization with avirulent PhoP c and commensal E. coli F18 induced IL-6 secretion (98.3 ng/ml in PhoP c and 71.4 ng/ml in F18), which was less than 354.5 ng/ml after WT infection (Figure 3b) . Additionally, our real-time PCR data indicated that WT Salmonella colonization induced a 12-fold increase of IL-6 at the mRNA level, whereas colonization with avirulent PhoP c and commensal E. coli F18 only induced only a onefold increase of IL-6 mRNA (data not shown). The other cytokine levels, such as that of TNF-a (Figure 3c) , were also significantly greater in WT Salmonella-infected mice (287 ng/ml) than that in PhoP c -(51 ng/ml) or E. coli F18-(58 ng/ml) infected mice. 
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Histological examination of tissues for in vivo WT Salmonella-treated mice supports the cytokine profile, demonstrating tissue inflammation in response to WT Salmonella. In vivo colonization with avirulent PhoP c induced less inflammation (data not shown).
Bacteria Modulate b-Catenin Phosphorylation
To determine where bacteria are acting to modulate b-catenin activity, we assessed phospho-b-catenin (p-b-catenin) levels in mouse colons after infection with WT and PhoP c Salmonella. b-Catenin has been shown to be primed at S45 by CKI (casein kinase I), allowing efficient subsequent serial phosphorylations by GSK-3b on residues T41, S37, and S33. 16 The phosphorylation of b-catenin on S33 and S37 is essential for b-catenin's recognition by the ubiquitin ligase b-TrCP, which targets it for subsequent degradation. 17 As demonstrated in Figure 3a , WT Salmonella infection increased p-b-catenin, whereas PhoP c and F18 decreased p-b-catenin in mouse colonic epithelial cells. The increased phosphorylated IkB (p-IkBa) is an indicator of the increased NF-kB activation. We further tested the p-IkBa in mouse colonic epithelial cells. WT Salmonella infection increased p-IkBa, whereas PhoP c and F18 decreased p-IkBa. A similar trend for p-b-catenin was also found in the cultured epithelial cell models-rat small IEC, IEC-18, Madin-Darby canine kidney (MDCK) epithelial cells, and the human epithelial cell line HCT116 (Figure 4d ). Phosphorylation of b-catenin, expressed as p-b-catenin ser33/37/ Thr41, increased in rat small IECs (IEC-18 cells) with WT bacterial colonization (Figure 4b ). MDCK cells demonstrated a similar response to WT Salmonella in vitro (Figure 4c ), indicating that this response was not specific to rodent cells.
Bacterial Modulation of GSK-3b Phosphorylation
GSK-3b, a critical negative regulator of b-catenin, also phosphorylates IkB, the inhibitor of NF-kB activity. Because of the potential interaction in the NF-kB and b-catenin pathways as a result of shared GSK-3b activity, we evaluated the activity of GSK-3b during bacterial infection.
GSK-3b is a constitutively active serine-threonine kinase. Site-dependent phosphorylation of GSK-3b can suppress or enhance its kinase activity. 18 Specifically phosphorylation of GSK-3b at Ser9 leads to inactivation of its kinase activity. 19 On the contrary, GSK-3b phosphorylation within the catalytic domain at Tyr216 stimulates GSK-3b kinase activity, resulting in phosphorylation and degradation of b-catenin.
19
Phosphorylated GSK-3b levels at Tyr216 and Ser9 are two opposite valid indicators of GSK-3b activity. 18 Increase of p-Tyr216 and decrease of p-Ser9 indicate the elevated GSK-3b activity, resulting in b-catenin degradation (mp-
In the streptomycin mouse model, WT Salmonella infection increased phosphorylated GSK-3b (pY216) in colonic epithelia by 50% within 6 h, whereas PhoP c decreased phosphorylated GSK-3b by 31%, compared to the control without any bacterial infection. In contrast, WT Salmonella infection decreased phosphorylated GSK-3b (Ser9) in colonic epithelia by 48% within 6 h, whereas PhoP c increased phosphorylated GSK-3b (Ser9) by 21% compared to the control without any bacterial infection (Figure 4a ). Bacterial infection did not change the total amount of GSK-3b (Figure 5a ) or GSK-3a, another member of the GSK-3 family (data not shown). Briefly, our data suggest that bacterial colonization alters GSK-3b activity by stimulating its phosphorylation, which, in turn, influences the b-catenin-mediated pathways by phosphorylating b-catenin in colonic epithelial cells.
We also established a GSK-3b siRNA system to knock down the total expression of GSK-3b in HCT116 cells. As shown here, the expression of total GSK-3b and phospho-GSK-3b was decreased by about 43% (Figure 5b , þ siRNA for GSK3b), whereas the GSK-3a expression was not altered. The degradation of the total IkBa was less in the siRNAtransfected cells compared to the non-siRNA-transfected cells in response to the WT Salmonella colonization (Figure 5b ). Additionally, real-time PCR data showed that the IL-8 mRNA was decreased in the siRNA-transfected cells compared to the non-siRNA-transfected cells in response to the WT Salmonella colonization (Figure 5c ). Further to examine the effects of GSK-3b on Salmonellainduced activation of the NF-kB pathway, we tested the protective function of LiCl, an inhibitor of GSK-3b, in a polarized human colonic epithelial cell line, HT29Cl.19A. Pretreatment for 24 h with LiCl reduced IL-8 secretion in response to WT Salmonella (Figure 5d and e). This response was not cell line specific, because polarized human colonic epithelial T84 cells demonstrated the same response as did the HT29Cl.19A cells to WT Salmonella after with LiCl pretreatment (Figure 5d ). Less WT Salmonella-induced IL-8 secretion was detected in the medium of T84 cells after LiCl pretreatment (Figure 5e ). These data are consistent with these in our previous report, which demonstrated that LiCl pretreatment can inhibit WT Salmonella-induced GRO/CINC-1 (rat IL-8) secretion in a non-transformed rat small intestine cell line. 10 Taken together, our siRNA and LiCl pretreatment data suggested that inhibition of GSK-3b is able to reduce the NF-kB activity in response to the Salmonella colonization.
b-Catenin Activation Negatively Regulates the NF-jB Pathway during Bacterial Colonization
To address the possible biochemical and physiological effects of b-catenin on the NF-kB pathway, we used a unique cell model: the human epithelial cell line HCT116 with only the mutant b-catenin allele. 20 The mutant b-catenin gene D45 represents a 3-bp deletion (TCT) that removes codon 45. ) expressing constitutively active b-catenin, IkBa was stabilized; NF-kB/DNA binding, and NF-kB transcriptional activity were repressed after WT Salmonella colonization. Accordingly, constitutively active b-catenin was found to inhibit the secretion of IL-8. To test the global effect of b-catenin activity on inflammatory stimulation, we measured relative IkB levels as an indicator of NF-kB activation after treatment with WT Salmonella, TNF-a, and commensal E. coli F18. In CTNNB1
WT/D45
, there was IkB degradation after treatment with WT Salmonella, E. coli F18, and TNF-a ( Figure 6 ). These cells responded like normal mouse tissue incubated with WT Salmonella (Figure 1 ). In HCT116 (CTNNB1 WTÀ ), which possesses only WT CTNNB1, the responses to the WT Salmonella, E. coli F18, or TNF-a stimulation were comparable to that in the parental HCT116 cells. However, in CTNNB1 À/D45
, there was less IkB degradation induced by À/D45 than that in the parental HCT116. Moreover, CTNNB1 À/D45 cells showed similar protection of IkBa after Salmonella, E. coli F18, or TNF-a stimulation (Figure 6b ) relative to the parental cells, and HCT116 (CTNNB1 WTÀ ) possessed only WT CTNNB1. Interestingly, the baseline of the p-IkBa was relatively low in CTNNB1 À/D45 cells. After Salmonella, E. coli F18, or TNF-a stimulation, the p-IkBa was still lower compared to the parental cells and HCT116 (CTNNB1 WTÀ ) (Figure 6c ). This suggests that the protective effect of constitutively active b-catenin is not strictly limited to Salmonella-induced IkBa degradation.
DISCUSSION
This study demonstrates a novel role for b-catenin in IECs as a constitutive negative regulator of inflammation in vivo. By physically binding to NF-kB and preventing its activation, bcatenin acts in much the same way as IkBa to inhibit NF-kB activity. In response to pathogenic bacteria, the physical interaction between b-catenin and NF-kB is compromised as a result of phosphorylation of b-catenin by GSK-3b. P-bcatenin is subsequently degraded, liberating NF-kB from its physical connection and repression by b-catenin. IkBa, the well-established negative regulator of NF-kB, is degraded in a similar manner as b-catenin after WT Salmonella infection. Following b-catenin and IkBa degradation, free NF-kB translocates to the nucleus, stimulating the production of proinflammatory cytokines such as IL-6 and IL-8. In contrast, colonization by the non-virulent Salmonella strain PhoP c repressed GSK-3b kinase activity, thus stabilizing total b-catenin and the b-catenin/NF-kB complex. As a result, IL-6 and TNF-a secretion were suppressed compared to the mice with WT infection.
Our findings indicate that stabilization of b-catenin by inhibiting GSK-3 b kinase activity has a significant effect in downregulating the NF-kB pathway in IECs. A recent report on Toll-like receptor (TLR) agonist-stimulated monocytes demonstrated that GSK-3b is a pivotal factor in controlling whether a pro-or anti-inflammatory response is elicited after TLR activation. 22 Inhibition of GSK-3 b activity switched the response after LPS stimulation from proinflammatory, IL-12 releasing to anti-inflammatory, IL-10 producing. This antiinflammatory response to TLR stimulation in monocytes demonstrated that GSK-3b could regulate the inflammatory responses. 22 A recent study in colon cancer and breast cancer cells has shown that inhibition of GSK-3b with LiCl can alter NFkB activity, and that this cross-regulation occurs through b-catenin. 23 Our published 10 and unpublished data showed that LiCl inhibition of GSK-3b significantly decreased the amount of IL-8 secretion in response to WT Salmonella in small and large IECs. siRNA of GSK-3b was able to reduce IkBa degradation and IL-8 mRNA expression. Collectively, these data indicate that the regulation of NF-kB activity by b-catenin stabilization is not restricted to epithelial cells, but is active in other cell lines as well. The involvement of GSK-3b phosphorylation and b-catenin in regulating the inflammatory cascade in response to bacterial challenge is not unique to Salmonella infection. The type three secretory system (TTSS)-dependent pathogen Yersinia stimulates GSK-3b phosphorylation during the early stages of macrophage infection. 24 It is known that the TTSS Ipa effector proteins play prominent and diverse roles in Shigella-induced infection. 25 Ipa is able to bind with b-catenin. IpaC-associated b-catenin is tyrosine phosphorylated and destabilized, thus allowing for bacterial invasion. 25 A study on Listeria showed that b-catenin and a-catenin are recruited to the site of bacterial entry, which is necessary for the dynamic events that induce the cytoskeletal rearrangement and plasma membrane extensions in bacterial uptake. 26 Our unpublished data also showed that WT enteropathogenic E. coli infection was able to reduce the total b-catenin expression in epithelial cells, whereas the phosphorylation of GSK-3b (Ser9) was increased. These results suggest that phosphorylation of GSK-3b and b-catenin stabilization provides important control points in the inflammatory cascade.
Our published data showed that AvrA, a bacterial effector in Salmonella, mediates the ubiquitination of b-catenin. 5 Additionally, we showed that AvrA inhibited the NF-kB pathways and consequently modulated cellular inflammation. 27 We believe that the bacterial effector AvrA regulates the activation of NF-kB through b-catenin stabilization. Future characterization of the precise function of AvrA in vivo will give new clues concerning microbial-host interaction in inflammation.
We propose that the Salmonella-induced proinflammatory cascade involves both the b-catenin and NF-kB pathways ( Figure 7) . WT Salmonella triggers the proinflammatory response, including IkBa degradation, NF-kB activation, and IL-8 secretion in epithelial cells. However, we have shown that the same stimulation by WT Salmonella also causes b-catenin degradation by increasing the activity of phosphorylated GSK-3b (Figure 7a ). We propose that phosphorylation of GSK-3b provides a pivotal control site for the stability of b-catenin, which not only controls the cell's fate, apoptosis vs proliferation, but also modulates the magnitude of inflammation, through the activity of NF-kB. Phosphorylation of b-catenin by GSK-3b destabilizes b-catenin and thus prevents its interference with NF-kB signaling. In contrast, non-pathogenic bacteria stabilize b-catenin by inhibiting b-catenin phosphorylation through GSK-3b and ubiquitination of b-catenin. 5 Stabilization of b-catenin represses NF-kB-dependent inflammatory pathways and inhibits IL-8 secretion during bacterial colonization (Figure 7b ).
In conclusion, we examined the role of GSK-3b in modulating the b-catenin response to WT Salmonella. Our data showed that bacteria modulate b-catenin stabilization by stimulating b-catenin phosphorylation through the kinase activity of GSK-3b. Pathogenic bacteria increased b-catenin phosphorylation by increasing GSK-3b activity, thus reducing the total b-catenin expression and b-catenin/NF-kB binding. On the other hand, non-pathogenic bacteria are capable of stabilizing b-catenin and activating the b-catenin pathway by inhibiting GSK-3b activity. Consequently, bcatenin levels are maintained and activation of the NF-kB pathway is prevented. This idea is in agreement with our results showing that stabilization of b-catenin represses NF-kB pathway activation and inhibits IL-8 or IL-6 secretion during bacterial colonization both in vitro 22 and in vivo. Thus, our findings suggest that activated b-catenin may play an important role in modulating bacteria-induced inflammatory responses. 
